TY - JOUR T1 - Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection JF - Liver Transpl Y1 - 2012 A1 - N A Terrault A1 - Roland, M.E. A1 - Schiano, T. A1 - Dove, L. A1 - Wong, M.T. A1 - Fred Poordad A1 - Ragni, M.V. A1 - Barin, B. A1 - Simon, D. A1 - Olthoff, K.M. A1 - Johnson, L. A1 - Stosor, V. A1 - Jayaweera, D. A1 - Fung, J. A1 - Sherman, K.E. A1 - Subramanian, A. A1 - Millis, J.M. A1 - Slakey, D. A1 - Berg, C.L. A1 - Carlson, L. A1 - Ferrell, L. A1 - Stablein, D.M. A1 - Odim, J. A1 - Fox, L. A1 - Stock, P.G. KW - Abdomen,Acute KW - Adult KW - Body Mass Index KW - California KW - Cohort Studies KW - coinfection KW - Disease KW - epidemiology KW - Female KW - Follow-Up Studies KW - Graft Rejection KW - Graft Survival KW - HCV KW - hepatitis KW - Hepatitis C KW - hepatitis C virus KW - Hepatitis C,Chronic KW - Hiv KW - HIV Infections KW - Human KW - Humans KW - Incidence KW - Infection KW - Kidney Transplantation KW - Liver KW - Liver Transplantation KW - Male KW - Middle Aged KW - Mortality KW - Multicenter Studies KW - older KW - Patients KW - Postoperative Complications KW - Prospective Studies KW - Research KW - Research Support KW - Risk Factors KW - San Francisco KW - Survival KW - Survival Analysis KW - Survival Rate KW - transplantation KW - Treatment Outcome KW - United States VL - 18 SP - 716-726 IS - 6 N1 - PMC3358510 ER -